Literature DB >> 15173092

High-level expression of the coxsackievirus and adenovirus receptor messenger RNA in osteosarcoma, Ewing's sarcoma, and benign neurogenic tumors among musculoskeletal tumors.

Wenguang Gu1, Akira Ogose, Hiroyuki Kawashima, Masayuki Ito, Tomoyuki Ito, Atsushi Matsuba, Hiroshi Kitahara, Tetsuo Hotta, Kunihiko Tokunaga, Hiroshi Hatano, Tetsuro Morita, Sayuri Urakawa, Tatsuya Yoshizawa, Hiroyuki Kawashima, Ryozo Kuwano, Naoto Endo.   

Abstract

PURPOSE: The sensitivity of human tumor tissues to infection with recombinant adenoviruses correlates with the expression of the coxsackievirus and adenovirus receptor (CAR). CAR has been shown to function as the primary receptor for adenoviruses and to play a critical role in adenovirus entry into host cells. It is important for clinical gene therapy to determine the expression level of CAR in tumor tissues. EXPERIMENTAL
DESIGN: We analyzed the expression of CAR mRNA in 154 musculoskeletal tumor tissues from 154 patients and 10 normal mesenchymal tissues from 3 patients using reverse transcription-PCR and real-time quantitative PCR. An adenovirus infection assay was performed in two cell lines that were established from CAR-positive osteosarcoma tissue and CAR-negative malignant fibrous histiocytoma tissue.
RESULTS: Ninety-nine of 154 tumors were detected as CAR positive by reverse transcription-PCR. We found that the expression levels of CAR mRNA varied markedly between different tumors as determined by real-time quantitative PCR. CAR mRNA was expressed at high levels in osteosarcoma, Ewing's sarcoma, neurofibroma, and schwannoma; at intermediate levels in exostosis, giant cell tumor, liposarcoma, synovial sarcoma, malignant peripheral nerve sheath tumor, and hemangioma; and at low levels in alveolar soft part sarcoma and desmoid. Whereas the osteosarcoma cell line that expressed a high level of CAR mRNA, like its parent tumor, had a high efficiency of adenovirus infection, the malignant fibrous histiocytoma cell line with almost undetectable expression of CAR mRNA, like its parent tumor, had a low efficiency of infection.
CONCLUSIONS: Our data showed the great variations in CAR mRNA expression among human musculoskeletal tumors and mesenchymal tissues and implicated the potential usefulness of adenoviral vectors in gene therapy for osteosarcoma, Ewing's sarcoma, neurofibroma, and schwannoma. Efficient transduction with adenovirus for gene therapy could be realized in appropriate, sensitive tumor types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173092     DOI: 10.1158/1078-0432.CCR-03-0345

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

1.  Analysis of the expression of coxsackievirus and adenovirus receptor in five colon cancer cell lines.

Authors:  Yassan Abdolazimi; Majid Mojarrad; Mehrdad Pedram; Mohammad Hossein Modarressi
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

2.  Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.

Authors:  Denis Y Logunov; Olga V Zubkova; Anna S Karyagina-Zhulina; Eugenia A Shuvalova; Andrei P Karpov; Maxim M Shmarov; Irina L Tutykhina; Yulia S Alyapkina; Natalia M Grezina; Natalia A Zinovieva; Lev K Ernst; Alexsandr L Gintsburg; Boris S Naroditsky
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

3.  Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus.

Authors:  Guidong Li; Hiroyuki Kawashima; Akira Ogose; Takashi Ariizumi; Yongjun Xu; Tetsuo Hotta; Yasuo Urata; Toshiyoshi Fujiwara; Naoto Endo
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-31       Impact factor: 4.553

4.  Osteoblastic and fibroblastic multicentric osteosarcoma.

Authors:  Raúl Romero Cabello; Carlos J Sánchez; Marco A Duran Padilla; José M De la Garza Navarro; Raul Romero Feregrino; Avissai Alcántara Vázquez; Mercedes Hernández González; Rodrigo Romero Feregrino
Journal:  BMJ Case Rep       Date:  2011-11-21

5.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

Review 6.  Orthopedic gene therapy in 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

7.  Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Authors:  David H Dreyfus; S Mark Tompkins; Ramsay Fuleihan; Lucy Y Ghoda
Journal:  Biologics       Date:  2007-12

8.  Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors.

Authors:  Inge Peerlinck; Saeid Amini-Nik; Robin K Phillips; Richard Iggo; Nicholas R Lemoine; Sabine Tejpar; Georges Vassaux
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: possible clinical implications.

Authors:  Costas T Giaginis; Apostolos C Zarros; Maria A Papaefthymiou; Aikaterini E Papadopouli; Ioannis K Sfiniadakis; Stamatios E Theocharis
Journal:  World J Surg Oncol       Date:  2008-06-17       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.